UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 142

Sortiert nach

Multicentric neoadjuvant pilot Phase II study of cetuximab combined with docetaxel in operable triple negative breast cancer

International journal of cancer, 2016-05, Vol.138 (9), p.2274-2280

2016

Link zum Volltext

Verfügbarkeit prüfen

Neoadjuvant endocrine therapy with or without palbociclib in low-risk patients: a phase III randomized double-blind SAFIA trial

Journal of cancer research and clinical oncology, 2023-08, Vol.149 (9), p.6171-6179

2023

Link zum Volltext

Verfügbarkeit prüfen

Anastrozole Is Superior to Tamoxifen as First-Line Therapy for Advanced Breast Cancer in Postmenopausal Women: Results of a North American Multicenter Randomized Trial

Journal of clinical oncology, 2000-11, Vol.18 (22), p.3758-3767

2000

Link zum Volltext

Verfügbarkeit prüfen

Comprehensive side-effect profile of anastrozole and tamoxifen as adjuvant treatment for early-stage breast cancer: long-term safety analysis of the ATAC trial

The lancet oncology, 2006-08, Vol.7 (8), p.633-643

2006

Link zum Volltext

Verfügbarkeit prüfen

A multicentre, international neoadjuvant, double-blind, randomized phase III trial comparing fulvestrant to a combination of fulvestrant and palbociclib (CDK 4/6 inhibitor) in patients with operable luminal breast cancer responding to fulvestrant (SAFIA study)

Annals of oncology, 2018-10, Vol.29, p.viii85-viii85

2018

Link zum Volltext

Verfügbarkeit prüfen

Anastrozole (Arimidex™) versus tamoxifen as first-line therapy for advanced breast cancer in postmenopausal women: survival analysis and updated safety results

European journal of cancer (1990), 2003-08, Vol.39 (12), p.1684-1689

2003

Link zum Volltext

Verfügbarkeit prüfen

Mastectomy with immediate breast reconstruction after neoadjuvant chemotherapy and radiation therapy. A new option for patients with operable invasive breast cancer. Results of a 20 years single institution study

European journal of surgical oncology, 2011-10, Vol.37 (10), p.864-870

2011

Link zum Volltext

Verfügbarkeit prüfen

Phase III, Multicenter, Double-Blind, Randomized Study of Letrozole, an Aromatase Inhibitor, for Advanced Breast Cancer Versus Megestrol Acetate

Journal of clinical oncology, 2001-07, Vol.19 (14), p.3357-3366

2001

Link zum Volltext

Verfügbarkeit prüfen

A longitudinal prospective study of health-related quality of life in breast cancer patients following high-dose chemotherapy with autologous blood stem cell transplantation

Bone marrow transplantation (Basingstoke), 2005-08, Vol.36 (3), p.251-259

2005

Link zum Volltext

Verfügbarkeit prüfen

Open-label randomised phase III trial of vinflunine versus an alkylating agent in patients with heavily pretreated metastatic breast cancer

Annals of oncology, 2018-04, Vol.29 (4), p.881-887

2018

Link zum Volltext

Verfügbarkeit prüfen

Prospective Randomized Trial of Docetaxel Versus Mitomycin Plus Vinblastine in Patients With Metastatic Breast Cancer Progressing Despite Previous Anthracycline-Containing Chemotherapy

Journal of clinical oncology, 1999-05, Vol.17 (5), p.1413-1424

1999

Link zum Volltext

Verfügbarkeit prüfen

Efficacy of tamoxifen following anastrozole (‘Arimidex’) compared with anastrozole following tamoxifen as first-line treatment for advanced breast cancer in postmenopausal women

European journal of cancer (1990), 2003-11, Vol.39 (16), p.2310-2317

2003

Link zum Volltext

Verfügbarkeit prüfen

Programme personnalisé de l’après cancer (PPAC): Quels sont les facteurs clés de succès de sa mise en œuvre ?

Oncologie (Paris, France), 2011-06, Vol.13 (6), p.295-302

2011

Link zum Volltext

Verfügbarkeit prüfen

Multicenter, randomized comparative study of two doses of paclitaxel in patients with metastatic breast cancer

Journal of clinical oncology, 1996-06, Vol.14 (6), p.1858-1867

1996

Link zum Volltext

Verfügbarkeit prüfen

Aromatase inhibitors in the management of early breast cancer

European journal of surgical oncology, 2008-11, Vol.34 (11), p.1199-1207

Nabholtz, J.M

2008

Link zum Volltext

Verfügbarkeit prüfen

Growth Factors and Cytokines Upregulate Gelatinase Expression in Bone Marrow CD34+ Cells and Their Transmigration Through Reconstituted Basement Membrane

Blood, 1999-05, Vol.93 (10), p.3379-3390

1999

Link zum Volltext

Verfügbarkeit prüfen

Phase II Study of Docetaxel, Doxorubicin, and Cyclophosphamide as First-Line Chemotherapy for Metastatic Breast Cancer

Journal of clinical oncology, 2001-01, Vol.19 (2), p.314-321

2001

Link zum Volltext

Verfügbarkeit prüfen

Late lines of treatment benefit survival in metastatic breast cancer in current practice?

Breast (Edinburgh), 2011-12, Vol.20 (6), p.574-578

2011

Link zum Volltext

Verfügbarkeit prüfen

Advanced breast cancer updates on anastrozole versus tamoxifen

Journal of steroid biochemistry and molecular biology, 2003-09, Vol.86 (3), p.321-325

Nabholtz, J.M

2003

Link zum Volltext

Verfügbarkeit prüfen

New adjuvant strategies for breast cancer: Meeting the challenge of integrating chemotherapy and trastuzumab (Herceptin)

Seminars in oncology, 2001-02, Vol.28 (1 Suppl 3), p.1-12

2001

Link zum Volltext

Verfügbarkeit prüfen

Prognostic Value of Initial Tumor Parameters After Metastatic Relapse

Cancer investigation, 2011-11, Vol.29 (9), p.635-643

2011

Link zum Volltext

Verfügbarkeit prüfen

Taxane/Anthracycline Combinations: Setting a New Standard in Breast Cancer?

The oncologist (Dayton, Ohio), 2001-01, Vol.6 (S3), p.5-12

2001

Link zum Volltext

Verfügbarkeit prüfen

Myasthenia gravis in association with allogeneic bone marrow transplantation : clinical observations, therapeutic implications and review of literature

Bone marrow transplantation (Basingstoke), 1997-05, Vol.19 (9), p.939-942

1997

Link zum Volltext

Verfügbarkeit prüfen

Ocular toxicity and cancer chemotherapy: A review

Cancer, 1996-10, Vol.78 (7), p.1359-1373

1996

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 142

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(133)
Mit Volltextzugriff
(110)

Publikationsform

Artikel
(142)

Sprache

Erscheinungsjahr

n.n

Thema

Humans
(77)
Female
(63)
Life Sciences & Biomedicine
(59)
Science & Technology
(59)
Oncology
(51)
Breast Neoplasms - Drug Therapy
(47)
Biological And Medical Sciences
(38)
Middle Aged
(38)
Medical Sciences
(36)
Aged
(33)
Adult
(32)
Breast Neoplasms - Pathology
(29)
Chemotherapy
(28)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(24)
Breast Cancer
(23)
Pharmacology. Drug Treatments
(22)
Neoplasm Metastasis
(21)
Antineoplastic Agents
(20)
Treatment Outcome
(18)
Taxoids
(16)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Multicentric neoadjuvant phase II study of panitumumab combined with an anthracycline/taxane-based chemotherapy in operable triple-negative breast cancer: identification of biologically defined signatures predicting treatment impact

Multicentric neoadjuvant pilot Phase II study of cetuximab combined with docetaxel in operable triple negative breast cancer

Neoadjuvant endocrine therapy with or without palbociclib in low-risk patients: a phase III randomized double-blind SAFIA trial

Anastrozole Is Superior to Tamoxifen as First-Line Therapy for Advanced Breast Cancer in Postmenopausal Women: Results of a North American Multicenter Randomized Trial

Comprehensive side-effect profile of anastrozole and tamoxifen as adjuvant treatment for early-stage breast cancer: long-term safety analysis of the ATAC trial

A multicentre, international neoadjuvant, double-blind, randomized phase III trial comparing fulvestrant to a combination of fulvestrant and palbociclib (CDK 4/6 inhibitor) in patients with operable luminal breast cancer responding to fulvestrant (SAFIA study)

Anastrozole (Arimidex™) versus tamoxifen as first-line therapy for advanced breast cancer in postmenopausal women: survival analysis and updated safety results

Mastectomy with immediate breast reconstruction after neoadjuvant chemotherapy and radiation therapy. A new option for patients with operable invasive breast cancer. Results of a 20 years single institution study

Phase III, Multicenter, Double-Blind, Randomized Study of Letrozole, an Aromatase Inhibitor, for Advanced Breast Cancer Versus Megestrol Acetate

A longitudinal prospective study of health-related quality of life in breast cancer patients following high-dose chemotherapy with autologous blood stem cell transplantation

Open-label randomised phase III trial of vinflunine versus an alkylating agent in patients with heavily pretreated metastatic breast cancer

Prospective Randomized Trial of Docetaxel Versus Mitomycin Plus Vinblastine in Patients With Metastatic Breast Cancer Progressing Despite Previous Anthracycline-Containing Chemotherapy

Efficacy of tamoxifen following anastrozole (‘Arimidex’) compared with anastrozole following tamoxifen as first-line treatment for advanced breast cancer in postmenopausal women

Programme personnalisé de l’après cancer (PPAC): Quels sont les facteurs clés de succès de sa mise en œuvre ?

Multicenter, randomized comparative study of two doses of paclitaxel in patients with metastatic breast cancer

Aromatase inhibitors in the management of early breast cancer

Growth Factors and Cytokines Upregulate Gelatinase Expression in Bone Marrow CD34+ Cells and Their Transmigration Through Reconstituted Basement Membrane

Phase II Study of Docetaxel, Doxorubicin, and Cyclophosphamide as First-Line Chemotherapy for Metastatic Breast Cancer

Late lines of treatment benefit survival in metastatic breast cancer in current practice?

Advanced breast cancer updates on anastrozole versus tamoxifen

New adjuvant strategies for breast cancer: Meeting the challenge of integrating chemotherapy and trastuzumab (Herceptin)

Prognostic Value of Initial Tumor Parameters After Metastatic Relapse

Taxane/Anthracycline Combinations: Setting a New Standard in Breast Cancer?

Myasthenia gravis in association with allogeneic bone marrow transplantation : clinical observations, therapeutic implications and review of literature

Ocular toxicity and cancer chemotherapy: A review

Suchergebnisse filtern